A review on salient pharmacological features of momordica charantia

International Journal of Pharmacology

Volumn 11, Issue 5, 2015, Pages 405-413

  Upadhyay, Aparna ^a   Agrahari, Pooja ^a   Singh, D K ^a  

^a D D U GORAKHPUR UNIVERSITY   (India)

Author keywords

Charantin; Cucurbitacin; Diabetes mellitus; Momordica charantia; Momordicin; Pharmacology

Indexed keywords

2 HEPTENAL; 2 HEXENAL; 3 HEXANOL; 4 ALPHA METHYLZYMOSTEROL; ALPHA SPINASTEROL; ASCORBIC ACID; BUTYLFUSAN; CAMPESTEROL; CYCLOEUCALENOL; FATTY ACID; HEXADECANAL; LECTIN; LOPHENOL; MENTHOL; METRONIDAZOLE; MOMORDICA CHARANTIA EXTRACT; MYSTENOL; NEROLIDOL; NONADIENAL; OLEIC ACID; PALMITIC ACID; PENTADECANOL; PENTANAL; POVIDONE IODINE; SITOGLUSIDE; SITOSTEROL; STEARIC ACID; TERPENOID; UNCLASSIFIED DRUG; UNINDEXED DRUG; VOLERIC ACID;

ANALGESIC ACTIVITY; ANTIDIABETIC ACTIVITY; ANTIFEEDANT ACTIVITY; ANTIINFLAMMATORY ACTIVITY; ANTIMALARIAL ACTIVITY; ANTIMICROBIAL ACTIVITY; ANTINEOPLASTIC ACTIVITY; ANTIOXIDANT ACTIVITY; ANTIPYRETIC ACTIVITY; ANTIVIRAL ACTIVITY; BREAST CANCER; CONTRACEPTION; HYPOCHOLESTEROLEMIA; HYPOGLYCEMIA; IMMUNOMODULATION; INFLAMMATION; LARVICIDAL ACTIVITY; METABOLIC SYNDROME X; MOMORDICA CHARANTIA; NEUROPROTECTION; NONHUMAN; PHYTOCHEMISTRY; PLANT STRUCTURES; REVIEW; WOUND HEALING;

EID: 84931390874     PISSN: 18117775     EISSN: 18125700     Source Type: Journal    
DOI: 10.3923/ijp.2015.405.413     Document Type: Review

References (96)

1. Abdollahi, M., A.B. Zuki, A. Rezaeizadeh, Y.M. Goh and M.M. Noordin, 2011. Effects of Momordica charantia aqueous extract on renal histopathological changes associated with streptozotocin-induced diabetes mellitus type II in neonatal rats. J. Med. Plant Res., 5: 1779-1787.
2. Ahmed, I., E. Adeghate, A.K. Sharma, D.J. Pallot and J. Singh, 1998. Effects of Momordica charantia fruit juice on islet morphology in the pancreas of the streptozotocindiabetic rat. Diabetes Res. Clin. Pract., 40: 145-151.
3. Ahmed, I., M.S. Lakhani, M. Gillett, A. John and H. Raza, 2001. Hypotriglyceridemic and hypocholesterolemic effects of anti-diabetic Momordica charantia (karela) fruit extract in streptozotocin-induced diabetic rats. Diabetes Res. Clin. Pract., 51: 155-161.
4. Asiamah, D., M. Verghese, J. Boateng, B. Kanda, L. Shackelford and L.T. Walker, 2011. Chemopreventive potential of bitter melon (Momordica charantia) against precancerous lesions in the colon of fisher 344 male rats. Int. J. Cancer Res., 7: 36-46.
5. Basch, E., S. Gabardi and C. Ulbricht, 2003. Bitter melon (Momordica charantia): A review of efficacy and safety. Am. J. Health Syst. Pharm., 60: 356-359.
6. Baynes, J.W., 1995. Mechanistic Approach to Diabetes. Ellis Horwood Limited, Chichester, UK., pp: 203-231.
7. Behera, T.K., J.E. Staub, S. Bohera and P.W. Simon, 2008. Bitter gourd and human health. Med. Aram. Plant Sci. Biotechnol., 1: 224-226.
8. Beloin, N., M. Gbeassor, K. Akpagana, J. Hudson, K. de Soussa, K. Koumaglo and J.T. Arnason, 2005. Ethnomedicinal uses of Momordica charantia (Cucurbitaceae) in Togo and relation to its phytochemistry and biological activity. J. Ethnopharmacol., 96: 49-55.
9. Birdee, G.S. and G. Yeh, 2010. Complementary and alternative medicine therapies for diabetes: A clinical review. Clin. Diabetes, 28: 147-155.
10. Chan, W.Y., P.P.L. Tam and H.W. Yeung, 1984. The termination of early pregnancy in the mouse by β-momorcharin. Contraception, 29: 91-100.
11. Costa, J.G.M., E.M.M. Nascimento, A.R. Campos and F.F.G. Rodrigues, 2011. Antibacterial activity of Momordica charantia (Curcubitaceae) extracts and fractions. J. Basic Clin. Pharma., 2: 45-51.
12. Cunnick, J.E., K. Sakamoto, S.K. Chapes, G.W. Fortner and D.J. Takemoio, 1990. Induction of tumor cytotoxic immune cells using a protein from the bitter melon (Momordica charantia). Cell. Immunol., 126: 278-289.
13. Dasgupta, A.A., A.A. Mukherjee and A. Mitra, 2009. Phyto-pharmacology of Momordica charantia linn. A review. J. Glob. Pharm. Tech., 3: 7-14.
14. Desai, U.T. and A.M. Musmade, 1998. Pumpkins, Squashes and Gourds. In: Handbook of Vegetable Science and Technology-Production, Composition, Storage and Processing, Salunkhe, D.K. and S.S. Kadam (Eds.). Marcel Dekker Inc., New York, pp: 273-297.
15. Dhalla, N.S., K.C. Gupta, M.S. Sastry and C.L. Malhotra, 1961. Chemical composition of the fruit of Momordica charantia L. Ind. J. Pharmacol., 23: 128-131.
16. Dhar, P., S. Ghosh and D.K. Bhattacharyya, 1999. Dietary effects of conjugated octadecatrienoic fatty acid (9 cis, 11 trans, 13 trans) levels on blood lipids and nonenzymatic In vitro lipid peroxidation in rats. Lipids, 34: 109-114.
17. Dixit, V.P., P. Khanna and S.K. Bhargava, 1978. Effects of Momordica charantia L. fruit extract on the testicular function of dog. Planta Medica, 34: 280-286.
18. Dutta, P.K., A.K. Chakravarty, U.S. Chowdhury and S.C. Pakrashi, 1981. Vicine, a Favism-inducing toxin from Momordica charantia Linn. seeds. Indian J. Chem., 20: 669-671.
19. Fang, E.F. and T.B. Ng, 2011. Bitter gourd (Momordica charantia) is a cornucopia of health: A review of its credited antidiabetic, anti-HIV and antitumor properties. Curr. Mol. Med., 11: 417-436.
20. Fang, E.F. and T.B. Ng, 2012. Can bitter gourd(Momordica charantia) be a novel therapy for human cancers? Med. Arom. Plants, Vol. 1. 10.4172/2167-0412.1000e101
21. Feng, Z., W.W. Li, H.W. Yeung, S.Z. Chen and Y.P. Wang et al., 1990. Crystals of α-momorcharin: A new ribosome-inactivating protein. J. Mol. Biol., 214: 625-626.
22. Ganju, K. and B. Puri, 1959. Mentha longifolia. Bioflavonoids from Indian vegetables and fruit. Indian J. Med. Res., 47: 563-570.
23. Garau, C., E. Cummings, D.A. Phoenix and J. Singh, 2003. Beneficial effect and mechanism of action of Momordica charantia in the treatment of diabetes mellitus: A mini review. Int. J. Diabetes Metab., 11: 46-55.
24. Gopalan, C., B.V.R. Sastri and S.C. Balasubramanian, 1993. Nutritive Value of Indian Foods. 2nd Edn., National Institute of Nutrition, Indian Council of Medical Research, Hyderabad, India, pp: 1-10.
25. Gorinstein, S., O. Martin-Belloso, A. Lojek, M. Ciz and R. Soliva-Fortuny et al., 2002. Comparative content of some phytochemicals in Spanish apples, peaches and pears. J. Sci. Food Agric., 82: 1166-1170.
26. Grover, J.K., S.S. Rathi and V. Vats, 2002. Amelioration of experimental diabetic neuropathy and gastropathy in rats following oral administration of plant (Eugenia jambolana, Mucurna pruriens and Tinospora cordifolia) extracts. Indian J. Expt. Biol., 40: 273-276.
27. Grover, J.K. and S.P. Yadav, 2004. Pharmacological actions and potential uses of Momordica charantia: A review. J. Ethnopharm., 93: 123-132.
28. Gunasekar, M., 2011. Anti-cancer effects of Momordica charantia in vitro. Ph.D. Thesis, University of Central Lancashire, Preston.
29. Gurbuz, I., C. Akyuz, E. Yesilada and B. Sener, 2000. Anti-ulcerogenic effect of Momordica charantia L. fruits on various ulcer models in rats. J. Ethnopharmacol., 71: 77-82.
30. Handa, G., J. Singh, M.L. Sharma, A. Kaul and R. Zafar, 1990. Hypoglycemic principle of Momordica charantia seeds. Indian J. Nat. Prod., 6: 16-19.
31. Hannum, S.M., 2004. Potential impact of strawberries on human health: A review of the science. Crit. Rev. Food Sci. Nutr., 44: 1-17.
32. Haque, M.E., M.B. Alam and M.S. Hossain, 2011. The efficacy of cucurbitane type triterpenoids, glycosides and phenolic compounds isolated from Momordica charantia: A review. IJPSR, 2: 1135-1146.
33. Heiser, Jr. C.B., 1979. The Gourd Book. University of Oklahoma Press, Norman, Oklahoma, pp: 1-99.
34. Horax, R., N. Hettiarachchy and S. Islam, 2005. Total phenolic contents and phenolic acid constituents in 4 varieties of bitter melons (Momordica charantia) and antioxidant activities of their extracts. J. Food Sci., 70: C275-C280.
35. Huang, H.L., Y.W. Hong, W.H. Wong, Y.N. Chen, J.H. Chyuan, C.J. Huang and P.M. Chao, 2008. Bitter melon (Momordica charantia L.) inhibits adipocyte hypertrophy and down regulates lipogenic gene expression in adipose tissue of diet-induced obese rats. Br. J. Nutr., 99: 230-239.
36. Jayasooriya, A.P., M. Sakono, C. Yukizaki, M. Kawano, K. Yamamoto and N. Fukuda, 2000. Effects of Momordica charantia powder on serum glucose levels and various lipid parameters in rats fed with cholesterol-free and cholesterol-enriched diets. J. Etanopharmacol., 72: 331-336.
37. Khanna, P., S.C. Jain, A. Panagariya, V.P. Dixit, 1981. Hypoglycemic activity of polypeptide-P from a plant source. J. Nat. Prod., 44: 648-655.
38. Krawinkel, M.B. and G. Keding, 2006. Bitter gourd Momordica charantia: A dietary approach to hyperglycemia. Nutr. Rev., 64: 331-337.
39. Lee, S.Y., S.H. Eom, Y.K. Kim, N.I. Park and S.U. Park, 2009. Cucurbitane-type triterpenoids in Momordica charantia Linn. J. Med. Plants Res., 3: 1264-1269.
40. Lee-Huang, S., P.L. Huang, P.L. Nara, H.C. Chen, H.F. Kung, P. Huang and H.I. Huang, 1990. MAP 30: A new inhibitor of HIV-1 infection and replication. FEBS Lett., 272: 12-18.
41. Lee-Huang, S., P.L. Huang, P.L. Huang, A.S. Bourinbaiar, H.C. Chen and H.F. Kung, 1995. Inhibition of the integrase of Human Immuno-deficiency Virus (HIV) type1 by anti-HIV plant proteins MAP30 and GAP31. Proc. Natl. Acad. Sci., 92: 8818-8822.
42. Leelaprakash, G., J.C. Rose, B.M. Gowtham, P.K. Javvaji and A.S. Prasad, 2011. In vitro antimicrobial and antioxidant activity of Momordica charantia leaves. Pharmacophore, 2: 244-252.
43. Leung, K.C., Z.Q. Meng and W.K.K. Ho, 1997. Antigenic determination fragments of α-momorcharin. Biochimica Biophysica Acta (BBA)-Gen. Subj., 1336: 419-424.
44. Leung, L, R. Birtwhistle, J. Kotecka, S. Hannah and S. Cuthbertson, 2009. Anti-diabetic and hypoglycaemic effects of Momordica charantia (bitter melon): A mini review. Brit. J. Nut., 102: 1703-1708.
45. Ling, B., G.C. Wang, J. Ya, M.X. Zhang and G.W. Liang, 2008. Antifeedant activity and active ingredients against Plutella xylostella from Momordica charantia leaves. Agric. Sci. China, 7: 1466-1473.
46. Lotlikar, M.M., and M.R.R. Rao, 1962. Note on a hypoglycaemic principle isolated from the fruits of Momordica charantia. J. Univ. Bombay, 29: 223-224.
47. Mahmood, A., G.K. Raja, T. Mahmood, M. Gulfraz and A. Khanum, 2012. Isolation and characterization of antimicrobial activity conferring component(s) from seeds of Bitter gourd (Momordica charantia). J. Med. Plants Res., 6: 566-573.
48. Malik, Z.A., M. Singh and P.L. Sharma, 2011. Neuroprotective effect of Momordica charantia in global cerebral ischemia and reperfusion induced neuronal damage in diabetic mice. J. Ethnopharmacol., 133: 729-734.
49. Marr, K.L., X.Y. Mei and N.K. Bhattarai, 2004. Allozyme, morphological and nutritional analysis bearing on the domestication of Momordica charantia L. (Cucurbitaceae). Econ. Bot., 58: 435-455. Miniraj, N., K.P. Prasanna and K.V. Peter, 1993. Bitter Gourd
50. Momordica SP. In: Genetic Improvement of Vegetable Plants, Kalloo, G. and B.O. Bergh (Eds). Pergamon Press, Oxford, UK., pp: 239-246.
51. Munoz, V., M. Souvain and G. Bourdy, 2000. The search for natural bioactive compounds through a multidisciplinary approach in Bolivia: Part II. Antimalarial activity of some plants used by Mosetena Indians. J. Ethnopharmacol., 69: 139-155.
52. Nadkarni, K.M., 1993. Indian Materia Medica. 1st Edn., Popular Prakashan Pvt. Ltd., Bombay, pp: 805-806.
53. Nahas, R. and M. Moher, 2009. Complementary and alternative medicine forthe treatment of type 2 diabetes. Can. Fam. Physician, 55: 591-596.
54. Nerurkar, P. and R.B. Ray, 2010. Bitter melon: antagonist to cancer. Pharmacol. Res., 27: 1049-1053. Nerurkar, P.V., Y.K. Lee, E.H. Linden, S. Lim, L. Pearson,
55. J. Frank and V.R. Nerurkar, 2006. Lipid lowering effects of Momordica charantia (Bitter melon) in HIV-1-protease inhibitor-treated human hepatoma cells, HepG2. Br. J. Pharmacol., 148: 1156-1164.
56. Nerurkar, P.V., Y.K. Lee and V.R. Nerurkar, 2010. Momordica charantia (bitter melon) inhibits primary human adipocyte differentiation by modulating adipogenic genes. BMC Comp. Altern. Med., Vol. 10. 10.1186/1472-6882-10-34
57. Nerurkar, P.V., L.M. Johns, L.M. Buesa, G. Kipyakwai and E. Volper et al., 2011. Momordica charantia (bitter melon) attenuates high-fat diet-associated oxidative stress and neuroinflammation. J. Neuroinflammation, Vol. 8.
58. Ojewole, J.A., S.O. Adewole and G. Olayiwola, 2005. Hypoglycaemic and hypotensive effects of Momordica charantia Linn (Cucurbitaceae) whole-plant aqueous extract in rats. Cardiovasc. J. South Afr., 17: 227-232.
59. Okabe, H., Y. Miyahara, T. Yamauchi, K. Mirahara and T. Kawasaki, 1980. Studies on the constituents of Momordica charantia L. Isolation and characterization of momordicosides A and B, glycosides of a pentahydroxy-cucurbitane triterpene. Chem. Pharm. Bull., 28: 2753-2762.
60. Omoregbe, R.E., O.M. Ikuebe and I.G. Ihimire 1996 Antimicrobial activity of some medicinal plants extracts on Escherichia coli, Salmonella paratyphi and Shigella dysenteriae. Afr. J. Med. Med. Sci., 25: 373-375.
61. Ooi, C.P., Z. Yassin and T.A. Hamid, 2010. Momordica charantia for type 2 diabetes mellitus. Cochrane Database Syst. Rev., 10.1002/14651858.CD007845.pub2
62. Patel, R., N. Mahobia, N. Upwar, N. Waseem, H. Talaviya and Z. Patel, 2010. Analgesic and antipyretic activities of Momordica charantia L. Fruits. J. Adv. Pharm. Tech. Res., 1: 415-418.
63. Prakash, A.O. and R. Mathur, 1976. Screening of Indian plants for antifertility activity. Indian J. Exp. Biol., 14: 623-626.
64. Prasad, V., V. Jain, D. Girish and A.K. Dorle, 2006. Wound-healing property of Momordica charantia L. fruit powder. J. Herb. Pharmacother., 6: 105-115.
65. Raman, A. and C. Lau, 1996. Anti-diabetic properties and phytochemistry of Momordica charantia L. (Cucurbitaceae). Phytomedicine, 2: 349-362.
66. Rastogi, R.P. and B.N. Mehrotra, 1998a. Compendium of Indian Medicinal Plants. 5th Edn., Vol. 6, Central Drug Research Institute, New Delhi, India, Pages: 549.
67. Rastogi, R.P. and B.N. Mehrotra, 1998b. Compendium of Indian Medicinal Plants. In: 3rd Edn., Central Drug Research Institute, National Institute of Science Communication, Lucknow, New Delhi, India, Pages: 430.
68. Rastogi, R.P. and B.N. Mehrotra, 1998c. Compendium of Indian Medicinal Plants. In: 4th Edn., Central Drug Research Institute, National Institute of Science Communication, Lucknow, New Delhi, India, Pages: 480.
69. Rastogi, R.P. and B.N. Mehrotra, 1998d. Compendium of Indian Medicinal Plants. Vol. 5, Central Drug Research Institute, National Institute of Science Communication, Lucknow, New Delhi, India, Pages: 278.
70. Rathi, S.S., J.K. Grover and V. Vats, 2002. The effect of Momordica charantia and Mucuna pruriens in experimental diabetes and their effect on key metabolic enzymes involved in carbohydrate metabolism. Phytother. Res., 16: 236-243.
71. Ray, R.B., A. Raychoudhuri, R. Steele and P. Nerurkar, 2010. Bitter melon (Momordica charantia) extract inhibits breast cancer cell proliferation by modulating cell cycle regulatory genes and promotes apoptosis. Cancer Res., 70: 1925-1931.
72. Raza, H., I. Ahmed, A. John and A.K. Sharma, 2000. Modulation of xenobiotic metabolism and oxidative stress in chronic streptozotocin-induced diabetic rats fed with Momordica charantia fruit extract. J. Biochem. Mol. Toxicol., 14: 131-139.
73. Reyes, M.E.C., B.H. Gildemacher and G.J. Jansen, 1994. Momordica L. In: Plant Resources of South-East Asia: Vegetables, Siemonsma, J.S. and K. Piluek (Eds.). Pudoc Scientific Publishers, Wageningen, The Netherlands, pp: 206-210.
74. Rivera, G., 1941. Preliminary chemical and pharmacological studies on cudeamor. Momordica charantia L. Am. J. Pharm., 113: 281-296.
75. Rodriguez, D.B., L.C. Raymundo, T.C. Lee, K.L. Simpson and C.O. Chichester, 1976. Carotenoid pigment changes in ripening Momordica c harantia fruits. Ann. Bot., 40: 615-624.
76. Roopashree, T.S., R. Dang, R.H.S. Rani and C. Narendra, 2008. Antibacterial activity of antipsoriatic herbs: Cassia tora, Momordica charantia and Calendula officinalis. Int. J. Applied Res. Nat. Prod., 1: 20-28.
77. Sankaranarayanan, J. and C.I. Jolly, 1993. Phytochemical, antibacterial and pharmacological investigations on Momordica charantia Linn., Emblica offidnalis gaertn and Curcuma longa linn. Ind. J. Pharm. Sci., 55: 6-13.
78. Santos, K.K.A., E.F.F. Matias, C.E. Sobral-Souza, S.R. Tintino and M.F.B. Morais-Braga et al., 2012. Trypanocide, cytotoxic and antifungal activities of Momordica charantia. Pharm. Biol., 50: 162-166.
79. Semiz, A. and A. Sen, 2007. Antioxidant and chemoprotective properties of Momordica charantia L. (bitter melon) fruit extract. Afr. J. Biotechnol., 6: 273-277.
80. Sharma, S., S. Tandon, B. Semwal and K. Singh, 2011.. Momordica charantia Linn.: A comprehensive review on Bitter Remedy. J. Pharmaceut. Res. Opin., 1: 42-47.
81. Shih, C.C., C.H. Lin, W.L. Lin and J.B. Wu, 2009. Momordica charantia extract on insulin resistance and the skeletal muscle GLUT4 protein in fructose-fed rats. J. Ethnopharmacol., 123: 82-90.
82. Singh, R.K., R.C. Dhiman and P.K. Mittal, 2006. Mosquito larvicidal properties of Momordica charantia Linn (Family: Cucurbitaceae). J. Vect. Borne. Dis., 43: 88-91. Srivastava, Y., H. Venkatakrishna-Bhatt, Y. Verma,
83. K. Venkaiah and B.H. Raval, 1993. Antidiabetic and adaptogenic properties of Momordica charantia extract: An experimental and clinical evaluation. Phytother. Res., 7: 285-289.
84. Subratty, A.H., F. Mahomoodally and A. Gurib-Fakim, 2005. Bitter Melon: An exotic vegetable with medicinal values. Nutr. Food Sci., 35: 143-147.
85. Tindall, H.D., 1983. Vegetables in the Tropics. 1st Edn., Macmillan Press, London, UK., Pages: 533.
86. Tsai, C.H., E.C.F. Chen, H.S. Tsay and C.J. Huang, 2012. Wild bitter gourd improves metabolic syndrome: A preliminary dietary supplementation trial. Nutr. J., Vol. 11. 10.1186/1475-2891-11-4
87. Udoh, P., C. Ojenikoh and F. Udoh, 2001. Antifertility effect of Momordica charantia (bitter gourd) fruit on the gonads on male guinea pigs. Global J. Pure Applied. Sci., 7: 627-631.
88. Ullah, M., M. Showkat, N.U. Ahmed, S. Islam and N. Absar, 2012. Evaluation of Momordica charantia L. fruit extract for analgesic and anti-inflammatory activities using in vivo assay. Res. J. Med. Plant, 6: 236-244.
89. Vesely, D.L., W.R. Graves and T.M. Lo, 1977. Isolation of gyanylate cyclase inhibitor from the balsam pear (Momordica charantia abreviata). Biochem. Biophys. Res. Commun., 77: 1294-1299.
90. Warrier, P.K., V.P.K. Nambiar and C. Ramakutty, 1995. Indian Medicinal Plants: A Compendium of 500 Species. Orient Longman Pvt. Ltd., Hyderabad, India, pp: 393-394.
91. Welihinda, J., E.H. Karunanayake, M.H.R. Sheriff and K.S.A. Jayasinghe, 1986. Effect of Momordica charantia on the glucose tolerance in maturity onset diabetes. J. Ethnopharmacol., 17: 277-282.
92. Williamson, E.M., 2002. Major Herbs of Ayurveda. 1st Edn., Churchill Livingstone, London, UK., ISBN-13: 978-1856174169, Pages: 182.
93. Xiang, C.P., C.Y. Wu and L.P. Wang, 2000. Analysis and utilization of nutrient composition in bitter gourd (Momordica charantia). J. Huazhong. Agric. Univ., 19: 388-390.
94. Yasui, H., 2002. Identification of antifeedants in bitter gourd leaves and their effect of feeding behavior of several lepidopteran species. Japan Agric. Res. Q., 36: 25-30.
95. Yesilada, E., I. Gurbuz and H. Shibata, 1999. Screening of Turkish anti-ulcerogenic folk remedies for anti-Helicobacter pylori activity. J. Ethnopharmacol., 66: 289-293.
96. Yuwai, K.E., K.S. Rao, C. Kaluwin, G.P. Jones and D.E. Rivett, 1991. Chemical composition of Momordica charantia L. fruits. J. Agric. Food Chem., 39: 1762-1763.